Treating four or more brain tumors with radiosurgery is safe and effective, translating to a survival benefit of up to 18 months for some patients. The study's findings suggest that tumor volume rather than the number of brain metastases should be used as a criterion for radiosurgery.
Researchers identified distinct genetic signatures and cancer stem cell populations driving different subtypes of ependymomas. These findings suggest individualized treatment approaches targeting specific cancer stem cell populations could improve outcomes for patients with these tumors.
A team of researchers from the University of Illinois at Urbana-Champaign has developed an alternative therapy to surgery for brain cancers. By engineering T-cell receptors with enhanced binding capacity, the approach aims to eradicate tumors with minimal side effects.
A new study has found that large sinus tumors can be successfully removed endoscopically, with a significant reduction in morbidity compared to traditional open procedures. The procedure involves using tiny scopes and cameras to remove the tumor, which was shown to have a lower recurrence rate than expected.
Dr Wayne Thomas will investigate the role of the sonic hedgehog signalling protein in medulloblastoma development and identify target genes that contribute to its formation. His research aims to improve treatment options and potentially prevent this childhood cancer.
Researchers identified two novel mutations in FGFR1 and PDGFRA, implicated in various cancers, suggesting potential for targeted therapies. The study aims to develop small molecules and antibodies to regulate mutated genes, offering new treatments for glioblastoma and other cancers.
A recent study published in the Journal of Clinical Oncology found that pediatric brain tumor survivors experience significant long-term effects from radiation and treatment. The study, led by Paul Fisher, MD, surveyed 134 former patients and discovered that those who received radiation had a poorer quality of life than those who only ...
Researchers developed a large brain tumor model and tested a genetically engineered virus delivering two proteins to the brain. The findings show that combined RAdTK and RAdFlt3L gene therapy eliminated glioblastoma multiforme in lab rats, increasing survival rates significantly.
MR spectroscopy enhances breast imaging by identifying chemical compounds in tumors, leading to increased cancer detection rates (94-100%) and improved accuracy (57%). This adds value to existing MR exams, reducing unnecessary biopsies and improving patient outcomes.
A study published by Massachusetts General Hospital found that radiofrequency ablation (RFA) is an effective long-term treatment for kidney tumors, with success rates of 100% for surface tumors and 78% for central tumors. The procedure has been used to treat over 100 renal cell carcinomas in 85 patients with similar results.
A phase I study found that glioma patients who responded to erlotinib treatment had higher levels of EGFR expression and amplification. The level of phosphorylated PKB/Akt was also associated with response to erlotinib, as well as time to progression.
Researchers found that a vaccine targeting TRP-2 improves chemotherapy sensitivity in brain tumors. The study showed significant improvements in patient survival and tumor response rates compared to conventional treatments.
A new fluorescence device using time-resolved laser-induced fluorescence spectroscopy (TR-LIFS) has been developed to detect atherosclerotic plaque and brain tumors. The technique shows promising results in distinguishing between inflamed and stable plaque areas, as well as detecting tumor cells left behind after surgery.
Glioblastoma multiforme, the most common and least curable form of brain tumors, may be targeted with new molecular therapies. Researchers identified a protein called Fra-1 that controls malignant features of brain tumor cells and a receptor for interleukin 13 that can be augmented by cytokines to increase treatment accessibility.
Researchers have found molecular changes in breast cancer that are similar to those occurring in brain tumors, providing new insights into disease progression and potential treatment targets. The study identified specific laminin isoform changes that coincide with blood vessel growth and metastasis in breast cancer.
Researchers have developed nanoparticles that can detect tumors using standard MRI equipment, allowing for earlier diagnosis. The particles can also deliver cancer-fighting drugs directly to malignant tumors, promising more effective treatment options.
Researchers have identified a previously unknown protein called Fra-1 that controls cancer cells' malignant characteristics and spread to healthy tissue. The discovery, made in glioblastoma brain tumors, suggests new treatment possibilities for multiple cancers.
A recent study published in Neurology found no evidence that cell phone use increases the risk of developing brain tumors. Researchers analyzed data from over 400 people with and without brain tumors and found no correlation between cell phone use frequency or duration and brain tumor incidence.
Researchers developed a functional diffusion map using MRI scans to track water diffusion in the brain, finding that changes predicted tumor response 10 weeks before traditional techniques. This method could spare patients from ineffective treatment and allow doctors to switch to more effective therapies.
Dr. Waldemar Debinski has developed a novel treatment approach for glioblastoma, the most aggressive form of brain cancer, by targeting specific receptors on cancer cells. The therapy combines a form of interleukin-13 with a toxin that kills cancer cells without damaging healthy tissue.
St. Jude Children's Research Hospital finds that upfront treatment with radiation followed by chemotherapy can cure brain tumors in children over 3 years old, raising survival rates to 78% for two-year event-free survival and 89% for overall survival. The study shows promise for treating relapse cases using ICE chemotherapy.
Researchers discovered a potent Vitamin A derivative, ATRA, that suppresses growth and induces cell death in childhood brain cancer cells. The gene OTX2 is abnormally amplified in medulloblastoma tumors, which can be targeted by ATRA-based therapy.
A new study in JAMA found that over 75% of patients with malignant brain tumors underwent common procedures like radiation therapy, MRI, or surgery. However, the study also discovered that some practice patterns contradict published guidelines, such as the infrequent use of chemotherapy and anti-depressant medications.
A new JAMA study found that brain tumor treatment varies greatly among patients, with inconsistent use of chemotherapy and anti-convulsant medication. The study also highlights the need for improved communication between healthcare providers and patients, as well as increased participation in clinical trials.
The study found significant variations in treatment practices for patients with malignant glioma, including differences in the use of radiation therapy, chemotherapy, and antidepressants. These variations were associated with differences in survival rates, highlighting the need for further investigation and potential improvements to tr...
Researchers found that K-RAS activation is a key factor in the development of tumors in neurofibromatosis 1. The study suggests that targeting K-RAS could lead to more effective treatment options for this genetic disorder.
Researchers found that new blood vessels and immune system cells are essential to tumor formation, making them promising drug targets; however, brain images used for diagnosis may not be informative.
Scientists have created a comprehensive map of brain genes that regulate brain development, linking specific genes to specific brain locations. The Mahoney Transcription Factor Atlas will aid researchers in studying brain tumors and other disorders.
A new study published in Cancer Cell reveals that combining radiation with antiangiogenic therapy can significantly slow tumor growth when administered at the right time. The research found that a unique time period exists during which this combination is most effective, making it a potential breakthrough in cancer treatment.
Benjamin Raphael, a UCSD postdoctoral researcher, has been awarded a $500,000 Burroughs Wellcome Fund Career Award to analyze tumor genome architectures and identify genes important for tumor growth. His work aims to develop cancer diagnostics and understand how tumors behave and progress.
Researchers at Cedars-Sinai Medical Center found that a genetically engineered virus delivering the protein hsFlt3L slowed tumor growth and increased immune cell production in laboratory rats with glioblastoma multiforme. The study may lead to a new treatment approach for patients with GBM.
Researchers at Sick Kids confirm that cancer stem cells are responsible for initiating and growing brain tumors in a mouse model. This discovery opens the door for new therapeutic targets to conquer brain tumors.
Researchers at St. Jude Children's Research Hospital found that white matter lesions caused by treatment can mimic cancer, leading to unnecessary treatment. The study also linked WMLs to a decline in neurocognitive function in children with brain tumors.
Researchers used DSC MRI to measure blood volume in eight patients with cerebral abscesses and four with malignant brain tumors. The study found no overlap in blood volume between the two groups, allowing for accurate distinction between abscesses and tumors.
Scientists have successfully used stem cells to restore movement in paralyzed rats by transplanting oligodendrocytes, a type of cell that insulates nerve signals. Additionally, researchers have delivered GDNF, a factor aiding neuron survival, to patients with Parkinson's and Huntington's diseases using genetically modified astrocytes.
Researchers at Cedars-Sinai Medical Center have discovered a mechanism by which brain tumors can evade the immune system, leading to impaired cellular immunity in patients with glioma. By blocking COX-2 expression, the study found that tumor-killing T cell responses can be restored, offering new potential treatments for brain tumors.
Researchers found that mice with brain tumors treated with stem cells showed increased blood supply and decreased tumor growth, living on average 50 percent longer than untreated mice. The Congress of Neurological Surgeons Annual Meeting presented this promising research.
A study by St. Jude Children's Research Hospital found that the protein Mrp4 limits penetration of topotecan into the brain, which could improve treatment for brain cancer. Over-expression of Mrp4 in tumors contributes to topotecan resistance in patients.
A recent study found that individuals with mental illness are at a higher risk of developing brain and lung cancers. The research, supported by the American Cancer Society and National Institute of Mental Health, suggests that people with mental health problems smoke more than the general population.
A study found that CyberKnife radiosurgery successfully controls growth and progression of symptomatic benign tumors, improving symptoms in 78% of patients. The treatment has a high local control rate of 96%, offering a promising option for patients not candidates for surgery.
A genetic predictive test identifies brain cancer patients who benefit from temozolomide, a targeted treatment. The study found a 46% survival rate for those with methylated MGMT promoter status.
Intraoperative MRI improved tumor removal by detecting additional tissue that needed to be removed, altering surgical strategy in 27.5% of cases. High-field MRI provides better image quality and reduced scan time, but its high cost is a limiting factor.
Researchers at St. Jude Children's Research Hospital have successfully treated medulloblastoma brain cancer in lab models by targeting a single protein in the hedgehog pathway, demonstrating potential for novel treatment approaches and improved outcomes for patients.
Scientists identified two proteins as the key switches controlling brain cancer cell growth, revealing a potential new target for glioblastoma treatment. The study found that blocking one protein enables the other to inhibit cancerous growth, offering hope for more effective therapies.
A study published in the Journal of Clinical Oncology found that 3D radiation therapy can effectively treat brain cancer in children without impairing cognitive development. The research suggests that radiation therapy can be a viable treatment option for young children, offering hope to families affected by this type of cancer.
A phase III study uses IL13-PE38QQR, a hybrid protein that attaches to specific receptors on tumor cells, to target residual GBM brain tumors. The treatment, convection-enhanced delivery, facilitates infusion of the drug into the brain, bypassing the blood-brain barrier.
Fluorescence spectroscopy can quickly and accurately discriminate between brain tumor and normal tissue, according to researchers at Cedars-Sinai Medical Center. The technique analyzes biochemical and functional changes in cells, providing high diagnostic specificity.
A vaccine targeting cancer-related antigens in glioblastoma cells appears to prolong patient survival by a median of 103 weeks. The dendritic cell vaccine generated an immune response against these antigens, significantly improving survival rates compared to patients without the treatment.
Researchers have developed an iron oxide nanoparticle that can outline brain tumors and other lesions for up to five days under MRI, providing a new imaging marker. This contrast agent has the potential to assist in image-guided brain surgery and improve diagnosis of neurological disorders.
Researchers at Cedars-Sinai Medical Center have developed a new approach to boost the immune response against gliomas, a type of brain tumor. By targeting the interleukin 10 gene in dendritic cells, they can increase the production of IL-12, leading to a stronger Th1 response and enhanced immune response against cancer cells.
A recent study by the American Academy of Neurology found that people with low incomes are at a higher risk of developing brain tumors. The study analyzed data from Michigan and found a significant difference in brain cancer rates between those with low incomes and those without, particularly among younger adults.
A subset of neural stem cells has been identified as having the ability to track malignant brain tumors called gliomas. The researchers found that astrocytic progenitors express a chemokine receptor called CXCR4, which is attracted by stromal-cell derived factor-1 (SDF-1) secreted by glioma cells.
Researchers found that NKT cells are attracted to tumors producing the chemokine CCL2, leading to better patient outcomes. Neuroblastomas with abnormally high levels of the cancer-causing gene MYCN contained fewer NKT cells and produced less CCL2.
Researchers used MR spectroscopy to analyze 27 patients with previously treated brain tumors and found that Choline, Creatine, and N-acetylaspartate were detectable markers for tumor identification. Early detection can lead to timely treatment and prevent unnecessary therapy.
Researchers have developed a technique called 2D CSI MRS that uses chemical signatures to distinguish between tumor recurrence, normal tissue, and treatment-related changes in the brain. This method has shown significant differences in chemical ratios for recurrent tumors versus treatment-altered tissue.
Researchers used microarray technology to compare gene expression in healthy flies and those with brain cancer, finding significant changes in 321 genes involved in metabolism, cell proliferation, and more. The study identified a key tumor-suppressor gene mutation that causes cancerous tissue growth and metastasis in flies.
Researchers from the University of Texas M. D. Anderson Cancer Center have developed a novel approach to gene therapy that harnesses mesenchymal progenitor cells (MSC) to target cancer metastasis. The strategy has shown promising results in animal studies, with MSC gene therapy curing up to 70% of mice implanted with human ovarian cancer.
A new imaging probe detects small tumors in the brain, providing crucial information to surgeons during operations. The technology uses near-infrared fluorescence optical imaging to identify tumor margins and improve surgical treatment.
Researchers discovered the ING4 gene's significant reduction in glioblastomas, which led to faster growth and complex blood vessel networks. The study found that ING4 suppresses angiogenesis by inhibiting NF-kappa B, offering potential targets for glioma treatment.
Researchers have identified a critical gene called Lgl1, which plays a vital role in shaping cell behavior during embryonic brain development. The study found that mice lacking this gene exhibit dramatic abnormalities and resemble human patients with medulloblastoma, a type of brain tumor.